A Study to Evaluate the Efficacy and Safety of BMN 111 in Children With Achondroplasia

NCT03197766 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

121

Enrollment

INDUSTRY

Sponsor class

Conditions

Achondroplasia

Interventions

DRUG: BMN 111
DRUG: Placebo

Sponsor

BioMarin Pharmaceutical